In our investigation, we established that COX4I2 was actively transferred from CAFs to osteosarcoma cells via exosomes, reducing intracellular Fe2+ and ROS levels, thereby suppressing ferroptosis, and promoting tumor proliferation. The gene discussed is COX4I2; the disease is neoplasm.